Skip to main content
. 2020 Aug 14;10:1470. doi: 10.3389/fonc.2020.01470

Figure 1.

Figure 1

High parity (≥5 deliveries) before breast cancer diagnosis predicted poor breast cancer-specific survival in the overall cohort (A) and separately in luminal B-like (HER2 negative) breast cancers (B). (C) Shows the long-term breast cancer-specific survival according to the intrinsic subtype immunohistochemical surrogates. TNBC, triple-negative breast cancer.